Pliant Therapeutics raises ~$200M in public offering, reports preliminary cash of $163.6M

PLIANT THERAPEUTICS, INC.

Preliminary cash, cash equivalents and short-term investments of $163.6M as of June 30, 2022.
Public offering of 10.8M shares at $18.50/share; gross proceeds ~$200M, up to $230M with overallotment.
Underwriters granted 30-day option to purchase up to 1.6M additional shares at same price.
Offering expected to close July 15, 2022.
Underwriting agreement with J.P. Morgan and Cowen.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.